FDA Inspection 1027562 - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - August 24, 2017

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany, with an inspection on August 24, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany
Inspection Date: August 24, 2017
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 1e78476d-5351-47de-8c53-bd1f0aae370e